BrainCheck, Inc. 7.5.0

Approximately 66% of cases of dementia remain undiagnosed, highlighting the need for early identification, which plays a pivotal role in slowing down the progression of such conditions. BrainCheck, an FDA-registered Class II medical device, serves as an assessment tool for cognitive function. It aids in the diagnosis of Alzheimer's and dementia within a brief 15-minute timeframe.

Please be advised that we suggest conducting tests and assessments using an iPad. It is important to note that BrainCheck is not intended to diagnose brain health conditions or provide treatment.